<DOC>
	<DOCNO>NCT02553928</DOCNO>
	<brief_summary>Evaluation safety tolerability 20 mg daily dose memantine compare 10 mg give twice daily patient dementia Alzheimer 's type MMSE range 5-18 .</brief_summary>
	<brief_title>Interventional , Randomised , Double-blind , Study Evaluate Safety Tolerability Once Daily Versus Twice Daily Memantine Treatment Patients With Dementia Alzheimer 's Type Mini Mental State Examination ( MMSE ) Range 5 - 18</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>The patient knowledgeable reliable caregiver accompany patient clinical visit study . The patient diagnosis probable AD consistent National Institute Neurological Communicative Disorders Stroke Alzheimer 's Disease Related Disorders Association ( NINCDSADRDA ) criterion . The patient Mini Mental State Examination ( MMSE ) score ≥ 5 ≤ 18 Screening visit The dose Memantine stable 20 mg day least 3 month prior screen . The patient history severe drug allergy hypersensitivity , know hypersensitivity IMP excipients . The patient one follow condition : Evidence and/or history clinically significant neurodegenerative disease serious neurological disorder Alzheimer 's disease include , limited , Lewy body dementia , FrontoTemporal dementia , Parkinson 's disease , Huntington 's disease , major cortical stroke , Multiple Sclerosis , major head trauma primary secondary cerebral neoplasm . The patient modify Hachinski ischemia score great 4 screen visit . The patient current psychiatric disorder Axis I disorder ( DSMIVTR™ criterion ) , establish primary diagnosis , AD The patient currently receive treatment unstable dose acetyl cholinesterase inhibitor The patient clinical significant abnormal screening value ( vital sign , laboratory , ecg , B12 . Other protocol define inclusion exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>